Anti‐pruritic effect of isothiocyanates: Potential involvement of toll‐like receptor 3 signaling

• Published in: Pharmacology research & perspectives Vol. 10; no. 6; pp. e01038 - n/a
• Main Authors: Moriyama, Masaki, Konno, Mitsuhiro, Serizawa, Kanako, Yuzawa, Natsumi, Majima, Yuki, Hayashi, Ikuo, Suzuki, Tomohiko, Kainoh, Mie
• Format: Journal Article
• Language: English
• Published: United States John Wiley & Sons, Inc 01.12.2022; John Wiley and Sons Inc; Wiley
• Subjects: Animals; Antipruritics - pharmacology; Antipruritics - therapeutic use; atopic dermatitis; Behavior; Chloroquine; Dermatitis; Drugs; Eczema; Electric currents; Humans; Invited Review; Invited Reviews; isothiocyanate; itch; Laboratory animals; Mice; Mice, Knockout; Oral administration; Pharmacology; Pruritus; Pruritus - chemically induced; Pruritus - drug therapy; Pruritus - metabolism; Skin - metabolism; Skin diseases; sulforaphane; Toll-Like Receptor 3 - therapeutic use; toll‐like receptor 3; Japan; chloroquine; pruritus; itch; isothiocyanate; sulforaphane; atopic dermatitis; toll-like receptor 3
• ISSN: 2052-1707; 2052-1707
• DOI: 10.1002/prp2.1038

The innate immune system has an emerging role as a mediator of neuro‐immune communication and a therapeutic target for itch. Toll‐like receptor 3 (TLR3) plays an important role in itch, as shown in TLR3 knock‐out mice. In this study, to evaluate effects of TLR3 inhibitors on histamine‐independent itch, we used two kinds of isothiocyanate (ITC). Both phenethyl isothiocyanate (PEITC) and sulforaphane (SFN) inhibited Poly I:C (PIC)‐induced signaling in the RAW264.7 cell line. We then investigated the anti‐pruritic effect of these compounds on PIC‐ and chloroquine (CQ)‐induced scratching behavior. PEITC and SFN both suppressed PIC‐evoked scratching behavior in mice, and PEITC also inhibited CQ‐induced acute itch. Finally, we examined the oxazolone‐induced chronic itch model in mice. Surprisingly, oral dosing of both compounds suppressed scratching behaviors that were observed in mice. Our findings demonstrate that TLR3 is a critical mediator in acute and chronic itch transduction in mice and may be a promising therapeutic target for pruritus in human skin disorders. It is noteworthy that SFN has potential for use as an antipruritic as it is a phytochemical that is used as a supplement. Isothiocyanates (ITCs) demonstrated an anti‐pruritic effect on histamine‐independent itch through the modulation of toll‐like receptor 3 signaling. The present results demonstrate ITCs might be promising drugs for the treatment of acute and chronic pruritus in human skin disorders.